A Us Hospital Economic Impact Model for Oritavancin In Absssi Patients With Risk of Mrsa Infections
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.2108
https://www.valueinhealthjournal.com/article/S1098-3015(14)04038-8/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1573
First Page :
A605
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04038-8&doi=10.1016/j.jval.2014.08.2108